Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Sertoli-Leydig cell tumors of the ovary: a Taiwanese Gynecologic Oncology Group study.

Weng CS, Chen MY, Wang TY, Tsai HW, Hung YC, Yu KJ, Chiang YC, Lin H, Lu CH, Chou HH.

Taiwan J Obstet Gynecol. 2013 Mar;52(1):66-70. doi: 10.1016/j.tjog.2012.03.001.

2.

A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors.

Gui T, Cao D, Shen K, Yang J, Zhang Y, Yu Q, Wan X, Xiang Y, Xiao Y, Guo L.

Gynecol Oncol. 2012 Nov;127(2):384-9. doi: 10.1016/j.ygyno.2012.07.114. Epub 2012 Jul 28.

PMID:
22850410
3.

Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database.

Bhat RA, Lim YK, Chia YN, Yam KL.

J Obstet Gynaecol Res. 2013 Jan;39(1):305-10. doi: 10.1111/j.1447-0756.2012.01928.x. Epub 2012 Jun 13.

PMID:
22691037
4.

Clinicopathologic features of ovarian Sertoli-Leydig cell tumors.

Zhang HY, Zhu JE, Huang W, Zhu J.

Int J Clin Exp Pathol. 2014 Sep 15;7(10):6956-64. eCollection 2014.

5.

Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.

Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT.

Obstet Gynecol. 1996 Apr;87(4):527-31.

PMID:
8602303
6.

Ovarian Sertoli-Leydig cell tumor: a report of seven cases and a review of the literature.

Xiao H, Li B, Zuo J, Feng X, Li X, Zhang R, Wu L.

Gynecol Endocrinol. 2013 Mar;29(3):192-5. doi: 10.3109/09513590.2012.738723. Epub 2012 Nov 23. Review.

PMID:
23173550
7.

Ovarian Sertoli-Leydig cell tumors. a retrospective MITO study.

Sigismondi C, Gadducci A, Lorusso D, Candiani M, Breda E, Raspagliesi F, Cormio G, Marinaccio M, Mangili G.

Gynecol Oncol. 2012 Jun;125(3):673-6. doi: 10.1016/j.ygyno.2012.03.024. Epub 2012 Mar 22.

PMID:
22446621
8.

Management of metastatic ovarian Sertoli-Leydig cell tumor with sporadic multinodular goiter: a case report and literature review.

Chi M, Gilman AD, Iroegbu N.

Future Oncol. 2011 Sep;7(9):1113-7. doi: 10.2217/fon.11.89. Review.

PMID:
21919698
9.

The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.

Silva EG, Gershenson DM, Malpica A, Deavers M.

Am J Surg Pathol. 2006 Nov;30(11):1367-71.

PMID:
17063075
10.

Ovarian Sertoli Leydig cell tumours in children and adolescents: an analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT).

Schneider DT, Orbach D, Cecchetto G, Stachowicz-Stencel T, Brummel B, Brecht IB, Bisogno G, Ferrari A, Reguerre Y, Godzinski J, Bien E, Calaminus G, Göbel U, Patte C.

Eur J Cancer. 2015 Mar;51(4):543-50. doi: 10.1016/j.ejca.2014.11.013. Epub 2014 Dec 13.

PMID:
25514863
11.

Unclassified ovarian gonadal stromal tumors. A clinicopathologic study of 32 cases.

Seidman JD.

Am J Surg Pathol. 1996 Jun;20(6):699-706.

PMID:
8651349
12.

Sertoli-Leydig cell tumor of the ovary: a clinicopathologic study of 10 cases.

Ayhan A, Tuncer ZS, Hakverdi AU, Yüce K, Ayhan A.

Eur J Gynaecol Oncol. 1996;17(1):75-8.

PMID:
8750520
13.

Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.

Cicin I, Saip P, Guney N, Eralp Y, Ayan I, Kebudi R, Topuz E.

Eur J Obstet Gynecol Reprod Biol. 2009 Oct;146(2):210-4. doi: 10.1016/j.ejogrb.2009.02.052. Epub 2009 May 5.

PMID:
19419810
14.

Therapy of advanced ovarian juvenile granulosa cell tumors.

Schneider DT, Calaminus G, Wessalowski R, Pathmanathan R, Harms D, Göbel U.

Klin Padiatr. 2002 Jul-Aug;214(4):173-8.

PMID:
12165898
15.

A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors.

Sun HD, Lin H, Jao MS, Wang KL, Liou WS, Hung YC, Chiang YC, Lu CH, Lai HC, Yu MH.

Gynecol Oncol. 2012 Feb;124(2):244-9. doi: 10.1016/j.ygyno.2011.10.015. Epub 2011 Oct 20.

PMID:
22019525
16.

Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.

Lee CW, Song MJ, Park ST, Ki EY, Lee SJ, Lee KH, Ryu KS, Park JS, Hur SY.

World J Surg Oncol. 2011 Oct 11;9:123. doi: 10.1186/1477-7819-9-123.

17.

Sertoli-Leydig cell tumor of the ovary.

Chen FY, Sheu BC, Lin MC, Chow SN, Lin HH.

J Formos Med Assoc. 2004 May;103(5):388-91.

PMID:
15216408
18.

Primary treatment and prognostic factors of carcinosarcoma of the ovary, fallopian tube, and peritoneum: a Taiwanese Gynecologic Oncology Group Study.

Lu CH, Chen IH, Chen YJ, Wang KL, Qiu JT, Lin H, Lin WC, Liou WS, Huang YF, Lin YS, Tee YT, Hung YC.

Int J Gynecol Cancer. 2014 Mar;24(3):506-12. doi: 10.1097/IGC.0000000000000083.

PMID:
24557435
19.

[Clinical analysis of 11 cases of ovarian Setoli-Leydig cell tumor].

Li B, Wu LY, Zhang WH, Li L, Ma SK, Liu LY.

Zhonghua Fu Chan Ke Za Zhi. 2004 May;39(5):334-7. Chinese.

PMID:
15196418
20.

Imaging of gynecological disease (2): clinical and ultrasound characteristics of Sertoli cell tumors, Sertoli-Leydig cell tumors and Leydig cell tumors.

Demidov VN, Lipatenkova J, Vikhareva O, Van Holsbeke C, Timmerman D, Valentin L.

Ultrasound Obstet Gynecol. 2008 Jan;31(1):85-91.

Items per page

Supplemental Content

Write to the Help Desk